Literature DB >> 17935258

A new locus-specific database (LSDB) for mutations in the TGFBR2 gene: UMD-TGFBR2.

Melissa Yana Frederic1, Dalil Hamroun, Laurence Faivre, Catherine Boileau, Guillaume Jondeau, Mireille Claustres, Christophe Béroud, Gwenaëlle Collod-Béroud.   

Abstract

The implication of mutations in the TGFBR2 gene, known to be involved in cancers, in Marfan syndrome (MFS) and later in Loeys-Dietz syndrome (LDS) and Familial Thoracic Aortic Aneurysms and Dissections (TAAD2) gives a new example of the complexity of one gene involved in multiple diseases. To date, known TGFBR2 mutations are not disease-specific and many mutations have to be accumulated before genotype-phenotype relationships emerge. To facilitate mutational analysis of the TGFBR2 gene, a locus-specific database has been set up with the Universal Mutation Database (UMD) software. The version of the computerized database contains 85 entries. A total of 12 mutations are reported to be involved in MFS, six in incomplete MFS, 30 in LDS type I, 10 in LDS type II, seven in TAAD2, and 20 in various cancers. The database is accessible online at http://www.umd.be (last accessed: 3 July 2007). (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17935258     DOI: 10.1002/humu.20602

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  6 in total

1.  Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia.

Authors:  Michael Benzinou; Frederic F Clermont; Tom G W Letteboer; Jai-Hyun Kim; Silvia Espejel; Kelly A Harradine; Juan Arbelaez; Minh Thu Luu; Ritu Roy; David Quigley; Mamie Nakayama Higgins; Musa Zaid; Bradley E Aouizerat; Johannes Kristian Ploos van Amstel; Sophie Giraud; Sophie Dupuis-Girod; Gaetan Lesca; Henri Plauchu; Christopher C W Hughes; Cornelius J J Westermann; Rosemary J Akhurst
Journal:  Nat Commun       Date:  2012-01-10       Impact factor: 14.919

2.  Curcumin Inhibition of TGFβ signaling in bone metastatic breast cancer cells and the possible role of oxidative metabolites.

Authors:  Andrew G Kunihiro; Julia A Brickey; Jennifer B Frye; Julia N Cheng; Paula B Luis; Claus Schneider; Janet L Funk
Journal:  J Nutr Biochem       Date:  2021-08-15       Impact factor: 6.048

Review 3.  A new sporadic case of early-onset Loeys-Dietz syndrome due to the recurrent mutation p.R528C in the TGFBR2 gene substantiates interindividual clinical variability.

Authors:  A Jamsheer; C Henggeler; J Wierzba; B Loeys; A De Paepe; Ch Stheneur; N Badziag; K Matuszewska; G Matyas; A Latos-Bielenska
Journal:  J Appl Genet       Date:  2009       Impact factor: 3.240

4.  The challenge of comprehensive and consistent sequence variant interpretation between clinical laboratories.

Authors:  Melanie G Pepin; Mitzi L Murray; Samuel Bailey; Dru Leistritz-Kessler; Ulrike Schwarze; Peter H Byers
Journal:  Genet Med       Date:  2015-04-02       Impact factor: 8.822

5.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals.

Authors:  François-Olivier Desmet; Dalil Hamroun; Marine Lalande; Gwenaëlle Collod-Béroud; Mireille Claustres; Christophe Béroud
Journal:  Nucleic Acids Res       Date:  2009-04-01       Impact factor: 16.971

6.  Functional validation reveals the novel missense V419L variant in TGFBR2 associated with Loeys-Dietz syndrome (LDS) impairs canonical TGF-β signaling.

Authors:  Margot A Cousin; Michael T Zimmermann; Angela J Mathison; Patrick R Blackburn; Nicole J Boczek; Gavin R Oliver; Gwen A Lomberk; Raul A Urrutia; David R Deyle; Eric W Klee
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-07-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.